Tealwood Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Other funds holding BMRN
GIA
FFBTD
KF
IWA
EFG
FFA
WC
MGI
NAM
Tealwood Asset Management's BMRN Position: Q3 2026 in Review
Tealwood Asset Management sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2026, closing a stake of 17,324 shares — an estimated $991K sold.
Tealwood Asset Management first reported a position in BMRN in Q4 2021 and held it in 19 quarters. The position peaked at $1.39M in Q4 2022. 25 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.
- Tealwood Asset Management reported no remaining BioMarin Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Tealwood Asset Management sold 17,324 BioMarin Pharmaceuticals shares in Q3 2026, an estimated $991K.
- Tealwood Asset Management first reported a position in BioMarin Pharmaceuticals in Q4 2021 and held it in 19 quarters.
- Tealwood Asset Management's BioMarin Pharmaceuticals position peaked at $1.39M in Q4 2022.
- 25 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.
Based on Tealwood Asset Management's 13F filing for Q3 2026, filed 13 Oct 2026.